Admetsys' FDA Breakthrough Designation Accelerates Arrival of Fully Autonomous Clinical Robotics in Hospital
Posted:
Admetsys Corporation, a biomedical technology company specializing in critical care automation, announced today that the FDA has designated its automated glucose control and continuous blood diagnostics system a Breakthrough Device.
Peter Kyle calls on employees and businesses to act now to get to grips with technology amid forecasts of job losses.
Breakthroughs such as the emergence of ChatGPT have sparked an investment boom in the technology, but also led to forecasts that…
The company will use the funds to increase the adoption of its new offering, Sage, across healthcare providers, payers and care management organizations.
Ellipsis Health, a company using AI voice agent technology, announced it has raised $45 million in a new…
Attendees
Sponsors and Exhibitors
Contact us